Abbott Laboratories (NYSE: ABT) and Dexcom (NASDAQ: DXCM) are two leading medical device companies that compete against one ...
GotCGM delivers real-time CGM visibility across watches, widgets, lock screens, cars, and calendars on iOS and Android.
Dexcom (Nasdaq:DXCM) said today that it has officially opened its manufacturing and office development in Athenry, Ireland.
CEO Robert B. Ford remains optimistic about the company's opportunity in the continuous glucose monitor (CGM) market.
Continuous glucose monitoring metrics may be able to predict future glycemic trajectories for children and adolescents with prediabetes, according to study findings published in Diabetes Technology & ...
Continuous glucose monitoring (CGM) is now the standard of care for people with type 1 diabetes in many countries, but its role in the management of type 2 diabetes is less well established. This is ...
Adults in the US who want to measure their blood glucose levels using a wearable sensor will soon be able to buy one over-the-counter (OTC) for the first time. The FDA has cleared Dexcom’s Stelo as ...
The next-generation CGM is now available in Sweden, with launches expected in Germany, Spain and Italy during the coming weeks as part of a ...
is a senior reporter and author of the Optimizer newsletter. She has more than 13 years of experience reporting on wearables, health tech, and more. Before coming to The Verge, she worked for Gizmodo ...
Tandem Diabetes Care, Inc.’s TNDM t:slim X2 insulin pump with Control-IQ+ automated insulin delivery (AID) technology is now compatible with Abbott’s FreeStyle Libre 3 Plus continuous glucose ...